Zeiss MyoCare and ZEISS MyoCare S continue to significantly slow the progression of myopia according to the latest two-year results from Asia presented at
A special screening in Chatswood, Sydney, of My Eyes, the Australian feature film that underscores the power of preventative eye care, will be
A six-month Return and Earn campaign is set to raise about AU$175,000 for Guide Dogs NSW/ACT. It costs around $50,000 and takes over two
Intalight has received a CE mark for its Dream OCT platform, allowing the company to commercialise the optical coherence tomography (OCT) device in Europe.
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
